-+ 0.00%
-+ 0.00%
-+ 0.00%

Merit Medical Q2 FY26 GAAP EPS rises 20% to USD 0.65; revenue increases 10% to USD 418.8 million

PUBT·07/30/2026 20:32:01
Listen to the news
Merit Medical Q2 FY26 GAAP EPS rises 20% to USD 0.65; revenue increases 10% to USD 418.8 million
  • Merit Medical Systems posted Q2 2026 net income of USD 38.8 million, up 19.09%, with GAAP EPS at USD 0.65, up 20%.
  • Revenue rose 10% to USD 418.8 million, while GAAP operating margin widened 2.1 percentage points to 14.4%.
  • Cash flow from operations fell 11% to USD 110 million year-to-date, with free cash flow down 14% to USD 76.6 million.
  • CEO Martha G. Aronson said results beat the high end of expectations, citing 9% organic constant-currency growth excluding a strategic divestiture.
  • Full-year 2026 guidance was raised to revenue of USD 1.631 billion-USD 1.643 billion, with non-GAAP EPS seen at USD 4.25-USD 4.35.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merit Medical Systems Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607301605PRIMZONEFULLFEED9800712) on July 30, 2026, and is solely responsible for the information contained therein.